WWW.GREYWOLFAH.COM
DEAD

Serial Number

87115139

Owner

Grey Wolf Animal Health Inc.

Attorney

George T. Wu

Filing Date

Jul 25, 2016

Add to watchlist:

No watchlists yet
View on USPTO

WWW.GREYWOLFAH.COM Trademark

Serial Number: 87115139

WWW.GREYWOLFAH.COM is a trademark filed by Grey Wolf Animal Health Inc. on July 25, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Grey Wolf Animal Health Inc. (3 trademarks)

Suite 300
Toronto, Ontario M5E1B5 , CA

Entity Type: 03

Trademark Details

Filing Date

July 25, 2016

Registration Date

Not Registered

Goods & Services

Veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; veterinary pharmaceutical preparations for periodontal diseases; veterinary pharmaceutical preparations for respiratory and reproductive diseases in dogs, cats, horses, cattle, goats and sheep; veterinary pharmaceutical preparations for the treatment of arthritis, muscle soreness and sprains; veterinary pharmaceutical preparations for the treatment of bacterial infections in dogs, cats, horses, cattle, goats and sheep; veterinary pharmaceutical preparations for the treatment of infectious diseases in poultry; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, Bluecomb, pneumonia; veterinary pharmaceutical preparations for the treatment of nutritional muscular dystrophy; veterinary pharmaceutical preparations for the treatment of parasites; veterinary pharmaceutical preparations for the treatment of vitamin deficiencies; veterinary pharmaceutical preparations for udder care; veterinary pharmaceuticals for parturition induction in swine; veterinary pharmaceutical preparations, namely, antiparasitics, anti-inflammatories, antibiotics, anti-infectives, reproductive hormone preparations, and dental preparations for preventing the build-up of plaque, bacteria and calculus; veterinary pharmaceutical preparations for restoring and improving the intestinal function in small and large animals; veterinary pharmaceutical preparations for the treatment of cancer and dermatological illnesses in dogs, cats, horses, cattle, goats and sheep; veterinary pharmaceutical preparations, namely, nutritional additives to foodstuffs for animals, injectable concentrates of vitamins; veterinary pharmaceutical preparations for the treatment of infectious respiratory and enteric diseases in animals; veterinary pharmaceutical preparations, namely treatments for anxiety and central nervous system disorders in companion animals; veterinary pharmaceutical preparations containing glycotechnology for the management of dermatitis, keratoseborrheic disorders, and otitis externa in dogs, cats, horses, cattle, goats and sheep; veterinary pharmaceutical preparations for the treatment of feline hyperthyroidism; veterinary pharmaceutical preparations for use in the treatment or prevention of fleas in companion animals; veterinary pharmaceutical preparations, namely, concomitant medication in the treatment of respiratory disease in young cattles, prevention of post-weaning respiratory disease, growth promotors, vitaminised antibiotic complexes, vitaminised mineral complexes, lactic bacteria for early, massive and prolonged seeding of the gut flora of newborn calves, polyvalent antihelmintics for cattle and sheep, anti-microbial feed premixes; veterinary pharmaceutical preparations, namely, for the prevention of stress; veterinary pharmaceutical preparations, namely, soluble powder for the prevention and treatment of poultry diseases; nutraceuticals, namely, dietary supplements and food supplements fortified with bacteria, enzymes, vitamins, minerals, protein, fibres and grains, for medical and veterinary purposes; nutritional additives for use as a nutritional supplement for medical and veterinary purposes, namely, nutritional additives containing bacteria, enzymes, vitamins, minerals, potato protein, fermented potato protein, and roughage, namely, fibres and grains; dietetic substances for medical and veterinary purposes for pigs, cattle and poultry, namely, dietetic supplements containing one or more of vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, niacin, potato protein and fermented potato protein for improving the yield of milk in ruminant animals, stimulating the rumen fermentation in ruminant animals, reducing viral infection pressure, reducing bacterial infection pressure, lowering birth mortality, improving low animal weight at birth, improving feed conversion, reducing the number of animal runts, increasing homogeneity in animal groups, improving animal fertility and increasing yields in animals; medicinal additives for foodstuffs for animals in the nature of nutritional supplements containing one or more of pomace, foodmix based on grain and pomace, carbohydrates, crude fibres, amino acids, minerals, bacteria, enzymes, vitamins, minerals, potato protein, fermented potato protein, and roughage, trace elements and vitamins; nutritional additives for animals, namely, non-medicinal additives for animal feed for use as nutritional supplements; disinfectants; antibacterial and antiseptic preparations for veterinary use, namely, hand washes, hand foams, gels and sprays; cloths, wipes, pads, tissues and sponges impregnated with antibacterial and antiseptic preparations

Operating a website providing information in the field of veterinary products, namely, veterinary pharmaceuticals, nutraceuticals for veterinary purposes, and antibacterial and antiseptic preparations for veterinary use

Hygienical products for veterinary purposes, namely, veterinary needles, hypodermic syringes for veterinary use

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 8, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 8, 2019 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2018 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 19, 2018 RCCK
ASSIGNED TO LIE
Jun 12, 2018 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 28, 2017 RCSC
ASSIGNED TO LIE
Nov 26, 2017 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 14, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
May 14, 2017 GNSL
SUSPENSION LETTER WRITTEN
May 14, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 11, 2016 GNRN
NON-FINAL ACTION E-MAILED
Nov 11, 2016 GNRT
NON-FINAL ACTION WRITTEN
Nov 11, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jul 30, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2016 NWOS
NEW APPLICATION ENTERED
Jul 28, 2016 NWAP